Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

TXN

Analysts' Recommendation for TXN Stock at $202.04

Texas Instruments shares rose 2.9% this afternoon to a price of $202.04. The stock is still trading within range of its average target price of $205.3, and over the last 52 weeks, it has recorded a 18.7% performance. Analysts have given the Large-Cap Semiconductors stock target prices ranging from $130.0 to $284.0 dollars per share, with an average rating of buy.

The stock has a very low short interest at 1.9%, and a short ratio of 2.54. The company's insiders own 0.39% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 90.5% of Texas Instruments's shares being owned by this investor type.

Institutions Invested in Texas Instruments

Date Reported Holder Percentage Shares Value
2024-12-31 Vanguard Group Inc 10% 93,567,277 $18,904,800,310
2024-12-31 Blackrock Inc. 9% 82,794,657 $16,728,246,321
2024-12-31 State Street Corporation 5% 42,346,142 $8,555,826,182
2024-12-31 JP Morgan Chase & Company 3% 23,762,589 $4,801,112,250
2024-12-31 Capital Research Global Investors 3% 22,978,065 $4,642,603,100
2024-12-31 Geode Capital Management, LLC 2% 21,554,142 $4,354,906,580
2024-12-31 Charles Schwab Investment Management, Inc. 2% 21,487,468 $4,341,435,432
2024-12-31 Wellington Management Group, LLP 2% 20,880,014 $4,218,702,390
2024-12-31 Bank of America Corporation 2% 15,078,721 $3,046,580,156
2024-12-31 Primecap Management Company 2% 14,370,519 $2,903,491,485

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Texas Instruments.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS